FDA wants investigation into Biogen drug approval
United States Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock on Friday requested an investigation into the approval of Biogen Inc.’s Aduhelm (aducanumab) treatment for Alzhe…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
